Combs Andrew 4
4 · Prelude Therapeutics Inc · Filed Jul 22, 2021
Insider Transaction Report
Form 4
Combs Andrew
Chief Chemistry Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-07-20+95,000→ 95,000 totalExercise: $31.23Exp: 2031-07-19→ Common Stock (95,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the total shares on July 20, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.